XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2020   84,000,000      
Beginning balance, value at Dec. 31, 2020 $ 374,000,000 $ 1,000,000 $ 192,000,000 $ 181,000,000  
Net income (loss) (7,000,000)     (7,000,000)  
Activity related to share-based compensation 2,000,000   2,000,000    
Ending balance (in shares) at Mar. 31, 2021   84,000,000      
Ending balance, value at Mar. 31, 2021 369,000,000 $ 1,000,000 194,000,000 174,000,000  
Beginning balance (in shares) at Dec. 31, 2020   84,000,000      
Beginning balance, value at Dec. 31, 2020 374,000,000 $ 1,000,000 192,000,000 181,000,000  
Net income (loss) 1,929,361        
Foreign currency translation adjustments 0        
Derivative instrument adjustments, net of tax 0        
Ending balance (in shares) at Jun. 30, 2021   85,000,000      
Ending balance, value at Jun. 30, 2021 396,000,000 $ 1,000,000 212,000,000 183,000,000  
Beginning balance (in shares) at Mar. 31, 2021   84,000,000      
Beginning balance, value at Mar. 31, 2021 369,000,000 $ 1,000,000 194,000,000 174,000,000  
Net income (loss) 8,700,776     9,000,000  
Activity related to share-based compensation (in shares)   1,000,000      
Activity related to share-based compensation 18,000,000   18,000,000    
Foreign currency translation adjustments 0        
Derivative instrument adjustments, net of tax 0        
Ending balance (in shares) at Jun. 30, 2021   85,000,000      
Ending balance, value at Jun. 30, 2021 $ 396,000,000 $ 1,000,000 212,000,000 183,000,000  
Beginning balance (in shares) at Dec. 31, 2021 119,904,001 120,000,000      
Beginning balance, value at Dec. 31, 2021 $ 1,988,000,000 $ 1,000,000 1,630,000,000 357,000,000 $ 0
Net income (loss) 51,000,000     51,000,000  
Activity related to share-based compensation 4,000,000   4,000,000    
Derivative instrument adjustments, net of tax 22,000,000       22,000,000
Ending balance (in shares) at Mar. 31, 2022   120,000,000      
Ending balance, value at Mar. 31, 2022 $ 2,065,000,000 $ 1,000,000 1,634,000,000 408,000,000 22,000,000
Beginning balance (in shares) at Dec. 31, 2021 119,904,001 120,000,000      
Beginning balance, value at Dec. 31, 2021 $ 1,988,000,000 $ 1,000,000 1,630,000,000 357,000,000 0
Net income (loss) 123,700,348        
Foreign currency translation adjustments (6,000,000)        
Derivative instrument adjustments, net of tax $ 32,000,000        
Ending balance (in shares) at Jun. 30, 2022 118,501,896 118,000,000      
Ending balance, value at Jun. 30, 2022 $ 2,077,000,000 $ 1,000,000 1,626,000,000 424,000,000 26,000,000
Beginning balance (in shares) at Mar. 31, 2022   120,000,000      
Beginning balance, value at Mar. 31, 2022 2,065,000,000 $ 1,000,000 1,634,000,000 408,000,000 22,000,000
Net income (loss) 72,931,504     73,000,000  
Activity related to share-based compensation 16,000,000   16,000,000    
Foreign currency translation adjustments (6,000,000)       (6,000,000)
Derivative instrument adjustments, net of tax 10,000,000       10,000,000
Employee stock plan issuance 2,000,000   2,000,000    
Repurchase and retirement of common stock (in shares)   (2,000,000)      
Repurchase and retirement of common stock $ (83,000,000)   (26,000,000) (57,000,000)  
Ending balance (in shares) at Jun. 30, 2022 118,501,896 118,000,000      
Ending balance, value at Jun. 30, 2022 $ 2,077,000,000 $ 1,000,000 $ 1,626,000,000 $ 424,000,000 $ 26,000,000